REFERENCES
1. Panaitescu AM, Syngelaki A, Prodan N, Akolekar R, Nicolaides KH.
Chronic hypertension and adverse pregnancy outcome: a cohort study.Ultrasound Obstet Gynecol . 2017;50(2):228-35.
2. Nzelu D, Dumitrascu-Biris D, Nicolaides KH, Kametas NA. Chronic
hypertension: first-trimester blood pressure control and likelihood of
severe hypertension, preeclampsia, and small for gestational age.Am J Obstet Gynecol . 2018;218(3):337.e1-.e7.
3. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia
part 1: current understanding of its pathophysiology. Nat Rev
Nephrol . 2014;10(8):466-80.
4. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The ”Great
Obstetrical Syndromes” are associated with disorders of deep
placentation. Am J Obstet Gynecol . 2011;204(3):193-201.
5. Akolekar R, Zaragoza E, Poon L, Pepes S, Nicolaides K. Maternal serum
placental growth factor at 11+ 0 to 13+ 6 weeks of gestation in the
prediction of pre‐eclampsia. Ultrasound in Obstetrics and
Gynecology . 2008;32(6):732-9.
6. O’Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, et
al. Accuracy of competing-risks model in screening for pre-eclampsia by
maternal factors and biomarkers at 11-13 weeks’ gestation.Ultrasound Obstet Gynecol . 2017;49(6):751-5.
7. Wright A, Wright D, Syngelaki A, Georgantis A, Nicolaides KH.
Two-stage screening for preterm preeclampsia at 11-13 weeks’ gestation.Am J Obstet Gynecol . 2019;220(2):197.e1-.e11.
8. Felmeden DC, Spencer CG, Blann AD, Beevers DG, Lip GY. Physical
activity in relation to indices of endothelial function and angiogenesis
factors in hypertension: a substudy of the Anglo-Scandinavian Cardiac
Outcomes Trial (ASCOT). J Intern Med . 2003;253(1):81-91.
9. Perni U, Sison C, Sharma V, Helseth G, Hawfield A, Suthanthiran M, et
al. Angiogenic factors in superimposed preeclampsia: a longitudinal
study of women with chronic hypertension during pregnancy.Hypertension . 2012;59(3):740-6.
10. Dinarello CA. Inflammatory cytokines: interleukin-1 and tumor
necrosis factor as effector molecules in autoimmune diseases. Curr
Opin Immunol . 1991;3(6):941-8.
11. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, Tsuruya Y, et al.
Interleukin 6 stimulates growth of vascular smooth muscle cells in a
PDGF-dependent manner. Am J Physiol . 1991;260(5 Pt 2):H1713-7.
12. Schiffrin EL. Endothelin: potential role in hypertension and
vascular hypertrophy. Hypertension . 1995;25(6):1135-43.
13. Ishizuka T, Takamizawa-Matsumoto M, Suzuki K, Kurita A. Endothelin-1
enhances vascular cell adhesion molecule-1 expression in tumor necrosis
factor alpha-stimulated vascular endothelial cells. Eur J
Pharmacol . 1999;369(2):237-45.
14. Robinson H, Fleming J. A critical evaluation of sonar “crown‐rump
length” measurements. BJOG: An International Journal of
Obstetrics & Gynaecology . 1975;82(9):702-10.
15. Tranquilli A, Dekker G, Magee L, Roberts J, Sibai B, Steyn W, et al.
The classification, diagnosis and management of the hypertensive
disorders of pregnancy: a revised statement from the ISSHP.Pregnancy Hypertens . 2014;4(2):97-104.
16. Panaitescu AM, Akolekar R, Kametas N, Syngelaki A, Nicolaides KH.
Impaired placentation in women with chronic hypertension who develop
pre-eclampsia. Ultrasound Obstet Gynecol . 2017;50(4):496-500.
17. Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC,
Klebanoff MA, et al. Soluble fms-Like tyrosine kinase 1 (sFlt1),
endoglin and placental growth factor (PlGF) in preeclampsia among high
risk pregnancies. PloS one . 2010;5(10):e13263.
18. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association
between inflammatory markers (C-reactive protein, interleukin-6, and
TNF-alpha) and essential hypertension. J Hum Hypertens .
2005;19(2):149-54.
19. Furumoto T, Saito N, Dong J, Mikami T, Fujii S, Kitabatake A.
Association of cardiovascular risk factors and endothelial dysfunction
in japanese hypertensive patients: implications for early
atherosclerosis. Hypertens Res . 2002;25(3):475-80.
20. Ito H, Ohshima A, Tsuzuki M, Ohto N, Takao K, Hijii C, et al.
Association of serum tumour necrosis factor-alpha with serum low-density
lipoprotein-cholesterol and blood pressure in apparently healthy
Japanese women. Clin Exp Pharmacol Physiol . 2001;28(3):188-92.
21. Yoshizumi M, Perrella MA, Burnett JC, Jr., Lee ME. Tumor necrosis
factor downregulates an endothelial nitric oxide synthase mRNA by
shortening its half-life. Circ Res . 1993;73(1):205-9.
22. O’Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D,
et al. Vascular cell adhesion molecule-1 is expressed in human coronary
atherosclerotic plaques. Implications for the mode of progression of
advanced coronary atherosclerosis. J Clin Invest .
1993;92(2):945-51.
23. Wolff K, Nisell H, Carlstrom K, Kublickiene K, Hemsen A, Lunell NO,
et al. Endothelin-1 and big endothelin-1 levels in normal term pregnancy
and in preeclampsia. Regul Pept . 1996;67(3):211-6.
24. Szarka A, Rigo J, Jr., Lazar L, Beko G, Molvarec A. Circulating
cytokines, chemokines and adhesion molecules in normal pregnancy and
preeclampsia determined by multiplex suspension array. BMC
Immunol . 2010;11:59.
25. Labarrere CA, DiCarlo HL, Bammerlin E, Hardin JW, Kim YM,
Chaemsaithong P, et al. Failure of physiologic transformation of spiral
arteries, endothelial and trophoblast cell activation, and acute
atherosis in the basal plate of the placenta. Am J Obstet
Gynecol . 2017;216(3):287.e1-.e16.
26. Staff AC, Johnsen GM, Dechend R, Redman CWG. Preeclampsia and
uteroplacental acute atherosis: immune and inflammatory factors. J
Reprod Immunol . 2014;101-102:120-6.
27. Widimsky J, Jr., Horky K, Dvorakova J. Plasma endothelin-1,2 levels
in mild and severe hypertension. J Hypertens Suppl .
1991;9(6):S194-5.
28. Opsjln SL, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A,
et al. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal
human pregnancy. Am J Obstet Gynecol . 1993;169(2 Pt 1):397-404.
29. Lygnos MC, Pappa KI, Papadaki HA, Relakis C, Koumantakis E, Anagnou
NP, et al. Changes in maternal plasma levels of VEGF, bFGF, TGF-beta1,
ET-1 and sKL during uncomplicated pregnancy, hypertensive pregnancy and
gestational diabetes. In Vivo . 2006;20(1):157-63.